Skip to main content

Table 4 Vaccine doses by age group up to 2021-07-15

From: Association of cerebral venous thrombosis with recent COVID-19 vaccination: case-crossover study using ascertainment through neuroimaging in Scotland

 

Pfizer

AstraZeneca

Moderna

Total doses

0–39

1,035,856 (39%)

378,507 (9%)

144,157 (84%)

1,558,520 (23%)

40–59

690,208 (26%)

1,837,077 (46%)

27,208 (16%)

2,554,493 (37%)

60 or more

963,420 (36%)

1815596 (45%)

862 (1%)

2,779,878 (40%)

4 (0%)

1113 (0%)

0 (0%)

1117 (0%)

Total doses

2,689,488

4,032,293

172,227

6,894,008